Lario Therapeutics Limited
Lario Therapeutics is dedicated to developing first-in-class precision medicines aimed at modifying diseases associated with severe neurological disorders, including epilepsy and Parkinson's disease. Their innovative pipeline focuses on genetically validated targets to slow disease progression.
Founded: 26 Nov 2021
Industries:
72110 - Research and experimental development on biotechnology
Website: lariotx.com
Phone: +441312433700
Email: info@lariotx.com
Location: Edinburgh
Products & Services
• biotechnology company
• disease modifying treatments
• disease modifying treatments for epilepsy
• disease modifying treatments for parkinson's disease
• epilepsy
• neurological disorders
• parkinson s disease
• precision medicine
• precision medicines for neurological disorders
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
3
Shareholders
9
Controllers (PSC)
2
Peter Michael Finan
Director • British • Lives in England • Born in Jul 1967
Henning Klaus-willi Christian Steinhagen
Director • German • Lives in Germany • Born in Nov 1969
Chiara Rossana Maria Liberati
Director • Italian • Lives in Italy • Born in Sept 1970
Basic Information
LTD
26 Nov 2021
SCOTLAND
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
5
Officers
2
PSCs
0
Filings